TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Rising Costs at NCI Threaten To Overtake Slim Increases In Budget Appropriations March 28, 2014
TCL Archive Leukemia Society, NCI, Discuss Funding, Congressional Language On Centers In January 14, 1994